Alyssa Panitch and Blaine Christainsen were awarded the CTSC Pilot Translation and Clinical Studies Program's Highly Innovative Award entitled: “Disease-Modifying Treatment for Osteoarthritis”. The funding will be used to efficate our hollow nanoparticle system to treat osteoarthritis in vivo.